Hong Kong lags behind Singapore in biotech race, but Greater Bay Area could prove its trump card

In Hong Kong, when you are not sure if you can plan ahead, it is very difficult to invest so much in a big business like biotech,” Hor said. Singapore’s current five-year plan, its sixth and covering …
( read original story …)

---